JPM Global Healthcare Fund A acc USD

Reference Data

ISIN LU0432979614
Valor Number 10261626
Bloomberg Global ID
Fund Name JPM Global Healthcare Fund A acc USD
Fund Provider J.P. Morgan Bank Luxembourg S.A. 6, route de Trèves
L-2633, Senningerberg
Grand Duchy of Luxembourg
Fund Provider J.P. Morgan Bank Luxembourg S.A.
Representative in Switzerland JPMorgan Asset Management (Switzerland) LLC
Genève
Phone: +41 22 744 11 11
Distributor(s) JP Morgan Asset Management (Europe) Sàrl
Senningerberg
Phone: +352 34 10 1
Asset Class Equities
EFC Category Equity Health Care
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition Combination of issuing commission charged by the fund management company and transaction fee charged by the fund
Redemption Condition Combination of redemption commission charged by the fund management company and transaction fee charged by the fund
Investment Strategy *** To achieve a return by investing primarily in pharmaceutical, biotechnology, healthcare services, medical technology and life sciences companies ("Healthcare Companies"), globally.
Peculiarities

Fund Prices

Current Price * 482.10 USD 31.03.2025
Previous Price * 485.69 USD 28.03.2025
52 Week High * 557.48 USD 03.09.2024
52 Week Low * 463.83 USD 20.12.2024
NAV * 482.10 USD 31.03.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 4,060,160,877
Unit/Share Assets *** 1,046,757,413
Trading Information SIX

Performance

YTD Performance +3.01% 31.12.2024
31.03.2025
YTD Performance (in CHF) -0.12% 31.12.2024
31.03.2025
1 month -3.14% 28.02.2025
31.03.2025
3 months +3.01% 31.12.2024
31.03.2025
6 months -9.21% 30.09.2024
31.03.2025
1 year -4.17% 02.04.2024
31.03.2025
2 years +4.12% 31.03.2023
31.03.2025
3 years -4.25% 31.03.2022
31.03.2025
5 years +43.44% 31.03.2020
31.03.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Eli Lilly and Co 10.18%
UnitedHealth Group Inc 7.09%
AbbVie Inc 6.69%
Johnson & Johnson 6.25%
AstraZeneca PLC 5.08%
Boston Scientific Corp 4.23%
Thermo Fisher Scientific Inc 3.87%
Sanofi SA 3.53%
Bristol-Myers Squibb Co 3.37%
Stryker Corp 3.35%
Last data update 28.02.2025

Cost / Risk

TER *** 1.69%
TER date *** 31.12.2024
Performance Fee ***
PTR
Max. Management Fee *** 1.50%
Ongoing Charges *** 1.69%
SRRI ***
SRRI date *** 28.02.2025

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)